Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Antibiotic comparison study in children with severe acute malnutrition
ISRCTN18051843Phase 3Completed
- Sponsor
- University of Oxford
- Start
- Jul 2017
- Modality
- Implantable Devices → Device-based Delivery → Drug Delivery Systems, Transdermal Patches → Device-based Delivery → Drug Delivery Systems, Nanoparticles → Drug Delivery Systems
01
Overview
Phase 3, randomised, double-blind trial of ceftriaxone, benzylpenicillin, gentamicin and metronidazole in bacterial disease and severe acute malnutrition (SAM) (4 arms), sponsored by University of Oxford. Primary endpoint: Mortality to day 90. Started Jul 2017; status: completed.
02
Drugs
ceftriaxonebenzylpenicillingentamicinmetronidazole
03
Conditions
bacterial diseasesevere acute malnutrition (SAM)
Beyond the preview
Go deeper on ISRCTN18051843.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN18051843.